This barrier is unrelated to the end of the transition period, following the United Kingdom's departure from the EU.

Public ID: PID-G22WPG

Lack of legislation regarding parallel imports of pharmaceutical products in Trinidad and Tobago

in Trinidad and Tobago

Trade barrier summary

Parallel imports negatively affect the UK pharmaceutical businesses' profits, and can put consumer's health at risk in the market. This is largely because some pharmaceuticals require special handling, storage and labelling, the absence of which can change the make-up of the pharmaceutical product, or reduce its effectiveness. Trinidad and Tobago laws state that once a product is registered in the local market, it can be imported and sold by anyone. This increases the number of unauthorised distributors selling a product, possibly at a cheaper price.

Sectors affected

  • Healthcare services
  • Pharmaceuticals and biotechnology



Date reported

13 May 2019

Last updated

2 February 2021

Public ID


Back to search results

If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .

If you export goods you can check duties and customs procedures for your chosen market.